Sterling Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$332K Buy
12,849
+2,937
+30% +$63.5K 0.01% 898
2026
Q2
$200K Sell
9,912
-473
-5% -$9.5K ﹤0.01% 1227
2026
Q1
$203K Sell
10,385
-6,217
-37% -$152K ﹤0.01% 1168
2025
Q4
$445K Buy
16,602
+4,935
+42% +$127K 0.01% 993
2025
Q3
$311K Buy
11,667
+1,450
+14% +$37.4K ﹤0.01% 1179
2025
Q2
$235K Buy
10,217
+898
+10% +$22.3K ﹤0.01% 1226
2025
Q1
$270K Hold
9,319
– – ﹤0.01% 1127
2024
Q4
$346K Hold
9,319
– – ﹤0.01% 1116
2024
Q3
$452K Buy
+9,319
New +$409K 0.01% 912

Other funds holding AMPH

Sterling Capital Management's AMPH Position: Q3 2026 in Review

Sterling Capital Management increased its Amphastar Pharmaceuticals (AMPH) stake by 30% in Q3 2026, buying an estimated $63.5K and bringing the position to 12,849 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #898.

Sterling Capital Management first reported a position in AMPH in Q3 2024 and has held it in 9 quarters since. The position peaked at $452K in Q3 2024. 180 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Sterling Capital Management held 12,849 shares of Amphastar Pharmaceuticals worth $332K as of Q3 2026.
  • Sterling Capital Management bought 2,937 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $63.5K.
  • Amphastar Pharmaceuticals made up 0.01% of Sterling Capital Management's portfolio in Q3 2026, its #898 holding.
  • Sterling Capital Management first reported a position in Amphastar Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
  • Sterling Capital Management's Amphastar Pharmaceuticals position peaked at $452K in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.